Australia · Delayed Price · Currency is AUD Cochlear Statistics
Total Valuation
Cochlear has a market cap or net worth of AUD 8.90 billion. The enterprise value is 8.93 billion.
| Market Cap | 8.90B |
| Enterprise Value | 8.93B |
Important Dates
The last earnings date was Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Share Statistics
Cochlear has 65.40 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 65.40M |
| Shares Outstanding | 65.40M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 68.10% |
| Float | 65.14M |
Valuation Ratios
The trailing PE ratio is 60.54 and the forward PE ratio is 26.13. Cochlear's PEG ratio is 2.17.
| PE Ratio | 60.54 |
| Forward PE | 26.13 |
| PS Ratio | 3.79 |
| PB Ratio | 5.11 |
| P/TBV Ratio | 7.08 |
| P/FCF Ratio | 29.00 |
| P/OCF Ratio | 24.19 |
| PEG Ratio | 2.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.28, with an EV/FCF ratio of 29.08.
| EV / Earnings | 60.60 |
| EV / Sales | 3.80 |
| EV / EBITDA | 17.28 |
| EV / EBIT | 21.18 |
| EV / FCF | 29.08 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.15 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 0.69 |
| Interest Coverage | 31.93 |
Financial Efficiency
Return on equity (ROE) is 7.98% and return on invested capital (ROIC) is 16.44%.
| Return on Equity (ROE) | 7.98% |
| Return on Assets (ROA) | 9.71% |
| Return on Invested Capital (ROIC) | 16.44% |
| Return on Capital Employed (ROCE) | 21.09% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | 434,741 |
| Profits Per Employee | 27,278 |
| Employee Count | 5,400 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 1.39 |
Taxes
In the past 12 months, Cochlear has paid 66.60 million in taxes.
| Income Tax | 66.60M |
| Effective Tax Rate | 31.14% |
Stock Price Statistics
The stock price has decreased by -54.89% in the last 52 weeks. The beta is 0.26, so Cochlear's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -54.89% |
| 50-Day Moving Average | 124.57 |
| 200-Day Moving Average | 175.91 |
| Relative Strength Index (RSI) | 61.53 |
| Average Volume (20 Days) | 433,667 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cochlear had revenue of AUD 2.35 billion and earned 147.30 million in profits. Earnings per share was 2.25.
| Revenue | 2.35B |
| Gross Profit | 1.66B |
| Operating Income | 421.50M |
| Pretax Income | 213.90M |
| Net Income | 147.30M |
| EBITDA | 479.90M |
| EBIT | 421.50M |
| Earnings Per Share (EPS) | 2.25 |
Balance Sheet
The company has 187.70 million in cash and 212.70 million in debt, with a net cash position of -25.00 million or -0.38 per share.
| Cash & Cash Equivalents | 187.70M |
| Total Debt | 212.70M |
| Net Cash | -25.00M |
| Net Cash Per Share | -0.38 |
| Equity (Book Value) | 1.74B |
| Book Value Per Share | 26.61 |
| Working Capital | 695.70M |
Cash Flow
In the last 12 months, operating cash flow was 368.00 million and capital expenditures -61.10 million, giving a free cash flow of 306.90 million.
| Operating Cash Flow | 368.00M |
| Capital Expenditures | -61.10M |
| Depreciation & Amortization | 58.40M |
| Net Borrowing | -36.20M |
| Free Cash Flow | 306.90M |
| FCF Per Share | 4.69 |
Margins
Gross margin is 70.69%, with operating and profit margins of 17.95% and 6.27%.
| Gross Margin | 70.69% |
| Operating Margin | 17.95% |
| Pretax Margin | 9.11% |
| Profit Margin | 6.27% |
| EBITDA Margin | 20.44% |
| EBIT Margin | 17.95% |
| FCF Margin | 13.07% |
Dividends & Yields
This stock pays an annual dividend of 2.60, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 2.60 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | -19.77% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 190.90% |
| Buyback Yield | 0.11% |
| Shareholder Yield | 2.03% |
| Earnings Yield | 1.65% |
| FCF Yield | 3.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Cochlear is 139.37, which is 2.40% higher than the current price. The consensus rating is "Hold".
| Price Target | 139.37 |
| Price Target Difference | 2.40% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 4.50% |
| EPS Growth Forecast (3Y) | 9.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cochlear has an Altman Z-Score of 12.6 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.6 |
| Piotroski F-Score | 5 |